329 related articles for article (PubMed ID: 26305552)
1. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.
Sun X; Gao D; Gao L; Zhang C; Yu X; Jia B; Wang F; Liu Z
Theranostics; 2015; 5(6):597-608. PubMed ID: 25825599
[TBL] [Abstract][Full Text] [Related]
3. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus.
Deng W; Chen W; Zhang Z; Huang S; Kong W; Sun Y; Tang X; Yao G; Feng X; Chen W; Sun L
Clin Immunol; 2015 Dec; 161(2):209-16. PubMed ID: 26209923
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
6. Cytoprotective effects of melatonin on zoledronic acid-treated human mesenchymal stem cells in vitro.
Rodríguez-Lozano FJ; García-Bernal D; Ros-Roca Mde L; Algueró Mdel C; Oñate-Sánchez RE; Camacho-Alonso F; Moraleda JM
J Craniomaxillofac Surg; 2015 Jul; 43(6):855-62. PubMed ID: 26026888
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell targeting by prenylation inhibitors elucidated in living animals with a bioluminescence reporter.
Chinault SL; Prior JL; Kaltenbronn KM; Penly A; Weilbaecher KN; Piwnica-Worms D; Blumer KJ
Clin Cancer Res; 2012 Aug; 18(15):4136-44. PubMed ID: 22693355
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.
Gallo M; De Luca A; Lamura L; Normanno N
Ann Oncol; 2012 Mar; 23(3):597-604. PubMed ID: 21551002
[TBL] [Abstract][Full Text] [Related]
9. The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
Luo KW; Ko CH; Yue GG; Gao S; Lee JK; Li G; Fung KP; Leung PC; Evdokiou A; Lau CB
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1025-36. PubMed ID: 25431338
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with Bisphosphonate Enhances Osteogenesis of Bone Marrow Mesenchymal Stem Cells.
Hu L; Wen Y; Xu J; Wu T; Zhang C; Wang J; Du J; Wang S
Stem Cells Dev; 2017 Jan; 26(2):123-132. PubMed ID: 27736364
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion.
Rietkötter E; Menck K; Bleckmann A; Farhat K; Schaffrinski M; Schulz M; Hanisch UK; Binder C; Pukrop T
Oncotarget; 2013 Sep; 4(9):1449-60. PubMed ID: 24036536
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2
Fowler DW; Copier J; Dalgleish AG; Bodman-Smith MD
Cancer Immunol Immunother; 2017 Sep; 66(9):1205-1215. PubMed ID: 28501938
[TBL] [Abstract][Full Text] [Related]
14. Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.
Zhang W; Zhu XD; Sun HC; Xiong YQ; Zhuang PY; Xu HX; Kong LQ; Wang L; Wu WZ; Tang ZY
Clin Cancer Res; 2010 Jul; 16(13):3420-30. PubMed ID: 20570927
[TBL] [Abstract][Full Text] [Related]
15. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.
Fragni M; Bonini SA; Bettinsoli P; Bodei S; Generali D; Bottini A; Spano PF; Memo M; Sigala S
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):529-38. PubMed ID: 26905520
[TBL] [Abstract][Full Text] [Related]
16. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
Daubiné F; Le Gall C; Gasser J; Green J; Clézardin P
J Natl Cancer Inst; 2007 Feb; 99(4):322-30. PubMed ID: 17312309
[TBL] [Abstract][Full Text] [Related]
18. Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
Ottewell PD; Lefley DV; Cross SS; Evans CA; Coleman RE; Holen I
Int J Cancer; 2010 Jan; 126(2):522-32. PubMed ID: 19621384
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Kuroda T; Kitadai Y; Tanaka S; Yang X; Mukaida N; Yoshihara M; Chayama K
Clin Cancer Res; 2005 Nov; 11(21):7629-36. PubMed ID: 16278381
[TBL] [Abstract][Full Text] [Related]
20. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
Fujimoto H; Sangai T; Ishii G; Ikehara A; Nagashima T; Miyazaki M; Ochiai A
Int J Cancer; 2009 Sep; 125(6):1276-84. PubMed ID: 19479998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]